Cargando…
A Cross-Sectional Study on Prescription Patterns of Short-Acting β(2)-Agonists in Patients with Asthma: Results from the SABINA III Colombia Cohort
PURPOSE: Overuse of short-acting β(2)-agonists (SABAs) for asthma is associated with a significant increase in exacerbations and healthcare resource use. However, limited data exist on the extent of SABA overuse outside of Europe and North America. As part of the multi-country SABA use IN Asthma (SA...
Autores principales: | Pedrozo-Pupo, John Carlos, Pacheco Gallego, Manuel Conrado, Baños Álvarez, Iván de Jesús, Jaller Raad, Rodolfo Antonio, Caballero Pinilla, Andrea Carolina, Reynales Londoño, Humberto, Bernal Villada, Laura, Beekman, Maarten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427209/ https://www.ncbi.nlm.nih.gov/pubmed/36051434 http://dx.doi.org/10.2147/JAA.S365009 |
Ejemplares similares
-
Short-acting β(2)-agonist prescription patterns in patients with asthma in Turkey: results from SABINA III
por: Yorgancıoğlu, Arzu, et al.
Publicado: (2022) -
Short-acting β(2)-agonist prescription patterns for asthma management in the SABINA III primary care cohort
por: Price, David, et al.
Publicado: (2022) -
Over-prescription of short-acting β(2)-agonists remains a serious health concern in Kenya: results from the SABINA III study
por: Chakaya, Jeremiah, et al.
Publicado: (2023) -
Over-prescription of short-acting β(2)-agonists for asthma in South Africa: Results from the SABINA III study
por: Smith, C, et al.
Publicado: (2022) -
Short-acting β(2)-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study
por: Bateman, Eric D., et al.
Publicado: (2022)